Controls are making the pharmaceutical market informal
Drugs in short supply are distributed on websites
The Venezuelan government tightened this year its grab on the pharmaceutical sector. Less foreign currency; more import requirements; establishment of the State-run network Farmapatria, and the implementation of a guide system for product handling are some of the government actions.
Add to the troubles noted by companies to supply the market due to these constraints, the warning about an increasingly informal market because of regulations.
Some sources have pointed to some irregularities in the marketing of pharmaceutical products; take for instance, the case of a sweetener in high demand in the domestic market.
The Ministry of Food shut the distribution of the product as the company responsible for marketing was denied the issuance of the Non-Production Certificate. It was disclosed that the company refused to lower the price, as suggested by the ministry.
The product vanished from the shelves of drugstores and supermarkets for a while. Now, it can be found, yet the pharmaceutical forms are not for the Venezuelan market. In some cases, the product lacks the health registry under domestic laws.
Translated by Conchita Delgado
A simple reason: there is oil galore, would suffice to explain Guyana's actions. Another explanation lies in the little or none efforts made by the Venezuelan government to thwart the move by the Guyanese. This is certainly not a new problem, but a problem only recently highlighted because oil is involved. But what other resources does the disputed area hold? For most of us it is a section on the map with black and white stripes on it, a depiction of something distant, alien, a nothingness not worth paying much attention to in geography classes back in elementary school.